Opposite effects of the acute promyelocytic leukemia PML-retinoic acid receptor alpha (RAR alpha) and PLZF-RAR alpha fusion proteins on retinoic acid signalling.

Por Ruthardt, M, Testa, U, Nervi, C, Ferrucci, P F, Grignani, F, Puccetti, E, Grignani, F, Peschle, C, Pelicci, P G
Publicado em 1997

Angiogenesis in myelodysplastic syndromes

Por Pruneri, G, Bertolini, F, Soligo, D, Carboni, N, Cortelezzi, A, Ferrucci, P F, Buffa, R, Lambertenghi-Deliliers, G, Pezzella, F
Publicado em 1999

Idarubicinol myelotoxicity: a comparison of in vitro data with clinical outcome in patients treated with high-dose idarubicin

Por Corsini, C, Ghielmini, M, Mancuso, P, Tealdo, F, Paolucci, M, Zucchetti, M, Ferrucci, P F, Cocorocchio, E, Mezzetti, M, Mori, A, Riggi, M, D'Incalci, M, Martinelli, G
Publicado em 2000

Effects on differentiation by the promyelocytic leukemia PML/RARalpha protein depend on the fusion of the PML protein dimerization and RARalpha DNA binding domains.

Por Grignani, F, Testa, U, Rogaia, D, Ferrucci, P F, Samoggia, P, Pinto, A, Aldinucci, D, Gelmetti, V, Fagioli, M, Alcalay, M, Seeler, J, Grignani, F, Nicoletti, I, Peschle, C, Pelicci, P G
Publicado em 1996

Baseline neutrophil-to-lymphocyte ratio is associated with outcome of ipilimumab-treated metastatic melanoma patients

Por Ferrucci, P F, Gandini, S, Battaglia, A, Alfieri, S, Di Giacomo, A M, Giannarelli, D, Cappellini, G C Antonini, De Galitiis, F, Marchetti, P, Amato, G, Lazzeri, A, Pala, L, Cocorocchio, E, Martinoli, C
Publicado no Br J Cancer (2015)

Ipilimumab retreatment in patients with pretreated advanced melanoma: the expanded access programme in Italy

Por Chiarion-Sileni, V, Pigozzo, J, Ascierto, P A, Simeone, E, Maio, M, Calabrò, L, Marchetti, P, De Galitiis, F, Testori, A, Ferrucci, P F, Queirolo, P, Spagnolo, F, Quaglino, P, Carnevale Schianca, F, Mandalà, M, Di Guardo, L, Del Vecchio, M
Publicado em 2014